A slew of National Institutes of Health grant terminations in the spring left affected Northwestern researchers with few ...

The Qatar Precision Health Institute (QPHI) is setting its sights on a bold transformation to make precision health part of ...

We applaud the FDA's decision to revise the labeling of fenofibrates (fibrates). The updated labeling now includes a clear statement on the lack of cardiovascular (CV) benefit, relevant safety data, ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...

Down-titrating vial concentrations when restarting subcutaneous allergen immunotherapy after treatment gaps may help lower ...

People with type 2 diabetes (T2D) and an elevated risk for cardiovascular disease (CVD) who took low-dose aspirin were less likely to experience a major cardiovascular event, including heart attack, ...

After percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) is recommended for 6 months in stable coronary artery disease1,2 and 12 months in acute coronary syndromes.3,4 Over the ...

If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

The FDA approved Lynkuet, a new nonhormonal menopause drug that reduces moderate to severe hot flashes and night sweats.

Vadodara: Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug ...

COLUMBUS, Ohio — Two Ohio bills that may have effects on abortion medication and access were considered in separate Ohio House committees this week. Opponents of a bill to further regulate medication ...

Geneva -- The World Health Organization sounded the alarm Monday over soaring numbers of drug-resistant bacterial infections, compromising the effectiveness of life-saving treatments and rendering ...